Sphere Medical Holding (LSE:SPHR) EBITDA Margin % : -10,000.00% (As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sphere Medical Holding's EBITDA for the six months ended in Dec. 2016 was £-2.40 Mil. Sphere Medical Holding's Revenue for the six months ended in Dec. 2016 was £0.02 Mil. Therefore, Sphere Medical Holding's EBITDA margin for the quarter that ended in Dec. 2016 was -10,000.00%.

Sphere Medical Holding EBITDA Margin % Historical Data

The historical data trend for Sphere Medical Holding's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding EBITDA Margin % Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

EBITDA Margin %

Get a 7-Day Free Trial

-16,582.61

-13,387.50

-40,807.14

-39,993.33

-16,640.00

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
EBITDA Margin %	Get a 7-Day Free Trial						-46,516.67	-34,150.00	-51,680.00	-43,200.00	-10,000.00

Competitive Comparison of Sphere Medical Holding's EBITDA Margin %

For the Medical Devices subindustry, Sphere Medical Holding's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sphere Medical Holding's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's EBITDA Margin % falls into.

Sphere Medical Holding EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sphere Medical Holding's EBITDA Margin % for the fiscal year that ended in Dec. 2016 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2016 )	/	Revenue (A: Dec. 2016 )
	=	-4.992	/	0.03
	=	-16,640.00 %

Sphere Medical Holding's EBITDA Margin % for the quarter that ended in Dec. 2016 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2016 )	/	Revenue (Q: Dec. 2016 )
	=	-2.4	/	0.024
	=	-10,000.00 %

Sphere Medical Holding (LSE:SPHR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sphere Medical Holding EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.